Translation and performance of the Norwegian SF-36 Health Survey in patients with rheumatoid arthritis. I. Data quality, scaling assumptions, reliability, and construct validity

Journal of Clinical Epidemiology

Volumn 51, Issue 11, 1998, Pages 1069-1076

  Loge, Jon Håvard ^a,b   Kaasa, Stein ^b,c   Hjermstad, Marianne Jensen ^d   Kvien, Tore K ^e  

^a UNIVERSITY OF OSLO   (Norway)

^b NORWEGIAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Norway)

^c Palliative Medicine Unit   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

^e DIAKONHJEMMET HOSPITAL   (Norway)

Author keywords

Cross cultural comparison; Health status indicators; Psychometrics; Reproducibility of results; Rheumatoid arthritis; SF 36 Health Survey

Indexed keywords

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CULTURAL FACTOR; FEMALE; HEALTH STATUS; HEALTH SURVEY; HUMAN; LANGUAGE; MAJOR CLINICAL STUDY; MALE; NORWAY; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; REPRODUCIBILITY; RHEUMATOID ARTHRITIS; VALIDATION PROCESS;

ARTHRITIS, RHEUMATOID; CROSS-CULTURAL COMPARISON; FEMALE; HEALTH STATUS INDICATORS; HUMANS; MALE; MIDDLE AGED; NORWAY; PSYCHOMETRICS; QUALITY OF LIFE; REPRODUCIBILITY OF RESULTS; TRANSLATIONS;

EID: 0032212645     PISSN: 08954356     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0895-4356(98)00098-5     Document Type: Article

References (21)

1. Ware J. The status of health assessment 1994. Annu Rev Public Health. 16:1995;327-354.
2. Aaronson N.K., Cull A., Kaasa S., Sprangers M.A.G. The EORTC modular approach to quality of life assessment in oncology. Int J Ment Health. 23:1994;75-96.
3. Cella D.F., Bonomi A.E. The functional assessment of cancer therapy (FACT) and functional assessment of HIV infection (FAHI) quality of life measurement system. Spilker B. Quality of Life and Pharmaeconomics in Clinical Trials, Second Edition. 1996;Lippincott-Raven Press, Philadelphia, PA.
4. McEwen J., McKenna S.P. Nottingham Health Profile. Spilker B. Quality of Life and Pharmaeconomics in Clinical Trials, Second Edition. 1996;Lippincott-Raven Press, Philadelphia, PA.
5. The Euro QoL Instrument: An index of health-related quality of life. In: Spilker B, Ed. Quality of Life and Pharmaeconomics in Clinical Trials, Second Edition. Philadelphia, PA: Lippincott-Raven Press; 1996: 91-201.
6. Szabo S. The World Health Organization quality of life (WHOQOL) assessment instrument. Spilker B. Quality of Life and Pharmaeconomics in Clinical Trials, Second Edition. 1996;Lippincott-Raven Press, Philadelphia, PA.
7. Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36) I. Conceptual framework and item selection. Med Care. 30:1992;473-483.
8. Aaronson N.K., Acquadro C., Alonso J., Apolone G., Bucquet D., Bullinger M.et al. International quality of life assessment (IQOLA) project. Qual Life Res. 1:1992;349-351.
9. Ware JE, Gandek B, Keller SD, IQOLA Group. Evaluating instruments used cross-nationally: Methods from the IQOLA Project. In: Spilker B, Ed. Quality of Life and Pharmaeconomics in Clinical Trials, Second Edition. Philadelphia, PA: Lippincott-Raven Press; 1996: 681-692.
10. Keller S.D., Ware J.E., Gandek B., Aaronson N.K., Alonso J., Apolone G.et al. Testing the equivalence of translations of widely-used response choice labels. Results from the IQOLA Project J Clin Epidemiol. 51(11):1998;933-944.
11. Kvien T.K., Glennås A., Knudsrød O.G., Smedstad L.M., Førre Ø The prevalence and severity of RA. Results from a hospital based register and a population survey (20-79 years) Arthritis Rheum. 38:1995;S258.
12. Kvien T.K., Kaasa S., Smedstad L.M. The performance of the Norwegian SF-36 health survey in patients with rheumatoid arthritis. II. A comparison of the SF-36 with disease-specific measures J Clin Epidemiol. 51(11):1998;1077-1086.
13. Ware J.E., Harris W.J., Gandek B., Rogers B.W., Reese P.R. MAP-R for Windows. Multitrait/Multi-item Analysis Program-Revised:1997;Health Assessment Lab, Boston, MA.
14. Ware J.E. The SF-36 health survey. Spilker B. Quality of Life and Pharmaeconomics in Clinical Trials, Second Edition. 1996;Lippincott-Raven Press, Philadelphia, PA.
15. How to Score the SF-36 Health Survey. Boston, MA: Medical Outcomes Trust; 1994.
16. Nunnally J.C. Psychometric Theory. 2:1978;McGraw-Hill, New York.
17. McHorney C.A., Ware J.E., Raczek A.E. The MOS 36-item health survey (SF-36). II. Psychometric and clinical tests of validity in measuring physical and mental health constructs Med Care. 31:1993;247-263.
18. Ware JE, Keller SD, Gandek B, Brazier JE, Sullivan M, IQOLA project group. Evaluating translations of health status questionnaires: Methods from the IQOLA project. Int J Technol Assess Health Care 1995; 11: 525-551.
19. Sullivan M., Karlsson J., Ware J.E. The Swedish SF-36 health survey. I. Evaluation of data quality, scaling assumptions, reliability and construct validity across general populations in Sweden. Soc Sci Med. 41:1995;1349-1358.
20. McHorney C.A., Ware J.E., Lu J.F.R., Sherbourne C.D. The MOS 36-item health survey (SF-36). III. Tests of data quality, scaling assumptions, and reliability across diverse patient groups Med Care. 32:1994;40-66.
21. Loge JH, Kaasa S. Interpreting subjective health status measures - normative data for SF-36. Scand J Soc Med 1998 (in press).